Note 9. Related Party Transactions

9 Months Ended

Sep. 30, 2015

Notes

Note 9. Related Party Transactions

Note 9. Related Party Transactions

At times, we have derived a portion of our revenues from sales of hyperthermia products.  A significant portion of those sales of hyperthermia products have been to a related party.  As described in Note 3 - Sale of Hyperthermia Assets, we sold all assets related to hyperthermia on April 1, 2015.  As a result, we have not recognized revenue from the sale of hyperthermia products subsequent to April 1, 2015.  In the three months ended September 30, 2015 we recognized other income of $84,000 under the terms of the Purchase Agreement between us and Pyrexar.  During the three months ended September 30, 2015 and 2014, we had sales of $0 and $27,087, respectively, to entities controlled by a significant stockholder and former member of the Board, representing approximately 0% and 3% of total revenues for each respective three-month period.  During the nine months ended September 30, 2015 and 2014, we had sales of $11,232 and $408,127, respectively, to these related parties, representing approximately 1% and 11% of total revenues, respectively. 

As of September 30, 2015 and December 31, 2014, receivables included $0 and $13,471, respectively, from these related parties.